From: PM2.5 exposure on daily cardio-respiratory mortality in Lima, Peru, from 2010 to 2016
Age Group | Β coefficient | RR | p | |
---|---|---|---|---|
Exp(Β)* | 95% CI | |||
All deaths circulatory (n = 35,664) | 0.0059 | 1.060* | 1.008 1.113 | 0.02 |
Q1st (11.27–17.07)a | 1.0 | 1.0 | ||
Q2nd (17.08–18.60) | 0.0386 | 1.039 | 0.999 1.081 | 0.054 |
Q3rd (18.61–20.58) | 0.0074 | 1.007 | 0.963 1.053 | 0.74 |
Q4th (20.59–25.23) | 0.0107 | 1.010 | 0.958 1.066 | 0.69 |
Q5th (25.24–60.18) | 0.0849 | 1.088 | 1.009 1.174 | 0.03 |
Age: 65 or more (n = 26,499) | 0.0061 | 1.062* | 1.001 1.127 | 0.04 |
Q1st (11.27–17.07)a | 1.0 | 1.0 | ||
Q2nd (17.08–18.60) | 0.0414 | 1.042 | 0.996 1.089 | 0.7 |
Q3rd (18.61–20.58) | 0.0368 | 1.037 | 0.986 1.091 | 0.15 |
Q4th (20.59–25.23) | 0.0352 | 1.035 | 0.974 1.101 | 0.26 |
Q5th (25.24–60.18) | 0.1055 | 1.111 | 1.017 1.214 | 0.02 |
CVD: all-age (32,937) | 0.0050 | 1.051 | 0.998 1.102 | 0.07 |
Q1st (11.27–17.07)a | 1.0 | 1.0 | ||
Q2nd (17.08–18.60) | 0.0351 | 1.035 | 0.993 1.079 | 0.10 |
Q3rd (18.61–20.58) | 0.0066 | 1.006 | 0.960 1.055 | 0.78 |
Q4th (20.59–25.23) | 0.0194 | 1.019 | 0.963 1.079 | 0.50 |
Q5th (25.24–60.18) | 0.0871 | 1.091 | 1.006 1.182 | 0.03 |
CVD: age 65 or more (24,890) | 0.0041 | 1.041 | 0.979 1.107 | 0.20 |
Q1st (11.27–17.07)a | 1.0 | 1.0 | ||
Q2nd (17.08–18.60) | 0.0376 | 1.038 | 0.990 1.088 | 0.12 |
Q3rd (18.61–20.58) | 0.0379 | 1.039 | 0.984 1.095 | 0.16 |
Q4th (20.59–25.23) | 0.0401 | 1.041 | 0.975 1.110 | 0.22 |
Q5th (25.24–60.18) | 0.1015 | 1.106 | 1.008 1.215 | 0.03 |